Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03064490 |
|---|---|
| Brief Title: | Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED) (PROCEED) |
| First Submitted : | February 22, 2017 |
| First Submitted that Met QC Criteria : | February 24, 2017 |
| First Posted : | February 27, 2017 |
| Last Update Submitted that Met QC Criteria : | December 7, 2022 |
| Last Update Posted : | December 8, 2022 |